PROMACTA

Novartis Pharmaceuticals Corporation🇺🇸 United States

FDA Page

Effective Date: Mar 26, 2024
Approval ID: 7714a0ed-34bb-46e6-a0a5-b363908b22c2
Products: 6 registered
Version: 26

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA (eltrombopag) tablets, for oral usePROMACTA (eltrombopag) for oral suspensionInitial U.S. Approval: 2008

Quick Stats

Total Products6

Labelers2

Label Sections39

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.